{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:39:51Z","timestamp":1787877591010,"version":"build-2784847793"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1097\/cm9.0000000000000970","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T20:23:24Z","timestamp":1597782204000},"page":"47-49","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Lipohypertrophy: prevalence, clinical consequence, and pathogenesis"],"prefix":"10.1097","volume":"134","author":[{"given":"Xiao-Han","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladmir","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Hu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s13300-016-0187-6","article-title":"Lipodystrophy in insulin-treated subjects and other injection-site skin reactions: are we sure everything is clear?","volume":"7","author":"Gentile","year":"2016","journal-title":"Diabetes Ther"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"67","DOI":"10.15171\/jcs.2018.011","article-title":"Lipohypertrophy in Individuals with type 2 diabetes: prevalence and risk factors","volume":"7","author":"S\u00fcr\u00fcc\u00fc","year":"2018","journal-title":"J Caring Sci"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3389\/fendo.2018.00638","article-title":"Insulin-related lipohypertrophy: lipogenic action or tissue trauma?","volume":"9","author":"Barola","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s13300-018-0472-7","article-title":"A systematic review of ultrasound-detected lipohypertrophy in insulin-exposed people with diabetes","volume":"9","author":"Abu Ghazaleh","year":"2018","journal-title":"Diabetes Ther"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2337\/dc16-0610","article-title":"Insulin injection into lipohypertrophic tissue: blunted and more variable insulin absorption and action and impaired postprandial glucose control","volume":"39","author":"Famulla","year":"2016","journal-title":"Diabetes Care"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.dsx.2016.09.010","article-title":"Assessment of insulin injection techniques among diabetes patients in a tertiary care centre","volume":"11","author":"Patil","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"R7-20250603","first-page":"13178","article-title":"Injection sites lipohypertrophy among 736 patients with type 2 diabetes of different-grade hospitals","volume":"9","author":"Li","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/dia.2016.0334","article-title":"Lipohypertrophy in China: prevalence, risk factors, insulin consumption, and clinical impact","volume":"19","author":"Ji","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s40064-016-1978-y","article-title":"A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes","volume":"5","author":"Gentile","year":"2016","journal-title":"Springerplus"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s40618-017-0675-1","article-title":"Ultrasound characterization of insulin induced lipohypertrophy in type 1 diabetes mellitus","volume":"40","author":"Bertuzzi","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/13506129.2016.1179183","article-title":"Insulin amyloid at injection sites of patients with diabetes","volume":"23","author":"Nilsson","year":"2016","journal-title":"Amyloid"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.diabet.2013.05.006","article-title":"Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes","volume":"39","author":"Blanco","year":"2013","journal-title":"Diabetes Metab"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.diabres.2018.02.005","article-title":"Skin complications of insulin injections: a case presentation and a possible explanation of hypoglycaemia","volume":"138","author":"Gentile","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"1205121","DOI":"10.1155\/2018\/1205121","article-title":"Factors affecting the absorption of subcutaneously administered insulin: effect on variability","volume":"2018","author":"Gradel","year":"2018","journal-title":"J Diabetes Res"},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2337\/dci15-0012","article-title":"Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association","volume":"38","author":"Fox","year":"2015","journal-title":"Diabetes Care"},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.dsx.2016.06.023","article-title":"Understanding diabetic foot infection and its management","volume":"11","author":"Noor","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/eye.2016.48","article-title":"Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus","volume":"30","author":"Stem","year":"2016","journal-title":"Eye (Lond)"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/jdi.12957","article-title":"Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes","volume":"10","author":"Lu","year":"2019","journal-title":"J Diabetes Investig"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.molmet.2019.10.005","article-title":"Diabetic kidney diseases revisited: a new perspective for a new era","volume":"30","author":"Fu","year":"2019","journal-title":"Mol Metab"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12913-018-3095-9","article-title":"The association between insurance coverage for insulin pen needles and healthcare resource utilization among insulin-dependent patients with diabetes in China","volume":"18","author":"Ji","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"R22-20250603","first-page":"1196","article-title":"Frequency of lipodystrophy induced by recombinant human insulin","volume":"15","author":"Hajheydari","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4103\/ijem.IJEM_548_16","article-title":"An audit of insulin usage and insulin injection practices in a large Indian cohort","volume":"21","author":"Baruah","year":"2017","journal-title":"Indian J Endocrinol Metab"},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"e20776","DOI":"10.5812\/ijem.20776","article-title":"Prevalence of lipohypertrophy and associated risk factors in insulin-treated patients with type 2 diabetes mellitus","volume":"13","author":"Al Ajlouni","year":"2015","journal-title":"Int J Endocrinol Metab"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/2230-8210.152762","article-title":"Forum for injection technique (FIT), India: the Indian recommendations 2.0, for best practice in insulin injection technique, 2015","volume":"19","author":"Tandon","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2337\/diaclin.34.1.51","article-title":"Concurrence of lipoatrophy and lipohypertrophy in children with type 1 diabetes using recombinant human insulin: two case reports","volume":"34","author":"Singha","year":"2016","journal-title":"Clin Diabetes"},{"key":"R28-20250603","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/dia.2017.0165","article-title":"An effective intervention for diabetic lipohypertrophy: results of a randomized, controlled, prospective multicenter study in France","volume":"19","author":"Campinos","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.diabres.2017.01.020","article-title":"UK lipohypertrophy interventional study","volume":"126","author":"Smith","year":"2017","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T20:34:50Z","timestamp":1748982890000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000000970","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]}}}